A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609)
伊匹木单抗和纳武利尤单抗治疗不可切除或转移性化生性乳腺癌的多中心 II 期试验：罕见肿瘤双重抗 CTLA-4 和抗 PD-1 阻断治疗队列 36 (DART, SWOG S1609)
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-21-2182
Adams, Sylvia; Othus, Megan; Patel, Sandip Pravin; Miller, Kathy D; Chugh, Rashmi; Schuetze, Scott M; Chamberlin, Mary D; Haley, Barbara J; Storniolo, Anna Maria V; Reddy, Mridula P; Anderson, Scott A; Zimmerman, Collin T; O'Dea, Anne P; Mirshahidi, Hamid R; Ahnert, Jordi Rodon; Brescia, Frank J; Hahn, Olwen; Raymond, Jane M; Biggs, David D; Connolly, Roisin M; Sharon, Elad; Korde, Larissa A; Gray, Robert J; Mayerson, Edward; Plets, Melissa; Blanke, Charles D; Chae, Young Kwang; Kurzrock, Razelle
